PCSK6 and pancreatic neoplasm: We demonstrated here that the inactivation of PCSK6 in cell lines of human pancreatic cancer could inhibit cell growth via inducing G0/G1 cell cycle arrest, and could impede cell migration that relied on the remodeling of cell–cell junctions and the cell skeleton.